A detailed history of Dimensional Fund Advisors LP transactions in Vaxart, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 77,823 shares of VXRT stock, worth $48,250. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77,823
Previous 79,100 1.61%
Holding current value
$48,250
Previous $45,000 124.44%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.56 - $1.41 $715 - $1,800
-1,277 Reduced 1.61%
77,823 $101,000
Q4 2023

Feb 07, 2024

SELL
$0.57 - $0.85 $6,837 - $10,195
-11,995 Reduced 13.17%
79,100 $45,000
Q3 2022

Nov 10, 2022

SELL
$2.09 - $4.5 $58,486 - $125,928
-27,984 Reduced 23.5%
91,095 $198,000
Q1 2022

May 13, 2022

SELL
$4.29 - $6.64 $3,041 - $4,707
-709 Reduced 0.59%
119,079 $600,000
Q4 2021

Feb 09, 2022

BUY
$5.77 - $7.96 $691,176 - $953,512
119,788 New
119,788 $751,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $78.4M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.